1[1]Hwang S J,Park J W,Lee S D,et al.Capectabine and Oxaliplatin (XELOX) for the treatment of patients with metastatic gastric cancer and severe liver dysfunction[J].Korean J Intern Med,2006,21 (4):252-255.
2黄翔.康莱特注射液治疗晚期肺癌28例疗效观察.中华实用医药杂志,2004,4(16):3-3.
3[3]Kang Y,Lee J,Min Y,et al.A randomized multi-center phase Ⅱ trial of capecitabine (X) versus S-1 (S) as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer[J].J Clin Oncol,2007,25 (185):4546.
2MacLellan SJ,MacKay HJ,Ringash J,Jacks L,Kassam Z,Conrad T,Khalili I,Okrainec A.Laparoscopic gastrectomy for patients with advanced gastric cancer produces oncologic outcomes similar to those for open resection.Surg Endosc 2012; 26: 1813-1821.
3Mori S,Kishimoto H,Tauchi K,Higuchi K.Histological complete response in advanced gastric cancer after 2 weeks of S-1 administration as neoadjuvant chemotherapy.Gastric Cancer 2006; 9: 136-139.
4Koizumi W,Kim YH,Fujii M,Kim HK,Imamura H,Lee KH,Hara T,Chung HC,Satoh T,Cho JY,Hosaka H,Tsuji A,Takagane A,Inokuchi M,Tanabe K,Okuno T,Ogura M,Yoshida K,Takeuchi M,Nakajima T.Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START).J Cancer Res Clin Oncol 2014; 140: 319-328.
5Tsukamoto T,Toyoda T,Mizoshita T,Tatematsu M.Helicobacter pylori infection and gastric carcinogenesis in rodent models.Semin Immunopathol 2013; 35: 177-190.
6Kozak KR,Moody JS.The survival impact of the intergroup 0116 trial on patients with gastric cancer.Int J Radiat Oncol Biol Phys 2008; 72: 517-521.
